0 Comments
0 Shares
830 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Memantine market driven by demand for Alzheimer's disease drugs connected with market driver outline as a part of headingThe global Memantine Market is estimated to be valued at US$ 565.93 Bn in 2022 and is expected to exhibit a CAGR of 3.87% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.Market Overview: Memantine is a prescription drug used for the treatment of moderate to severe Alzheimer's disease. It belongs to a class of drugs called NMDA receptor...0 Comments 0 Shares 1K Views 0 Reviews
-
Memantine Market Poised for Growth Due to Advancements in Alzheimer's Disease TreatmentMemantine is a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist primarily used for treating moderate to severe Alzheimer's disease. It functions by regulating glutamate activity and providing neuroprotection against toxicity. Memantine is approved as a treatment option either as a monotherapy or in combination with cholinesterase inhibitors for patients suffering from moderate to...0 Comments 0 Shares 390 Views 0 Reviews